Point-of-care Biosensors Market 2025 to 2034
Point-of-care Biosensors Market 2025 to 2034
Point-of-Care Biosensors Market (By Product: Glucose Monitoring, HIV, Hepatitis C, Pregnancy; By Platforms: Microfluidics, Dipsticks, Immunoassays; By Purchase: OTC, Prescription; By Sample: Blood, Urine; By End User: Pharmacy, Hospital, Homecare) Industry Size, Share, Growth, Trends 2025 to 2034.
Customisation Request
Revenue, 2025
USD 90.65 Bn
Forecast Year, 2034
USD 186.71 Bn
CAGR, 2025 - 2034
8.25%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global point-of-care biosensors market, valued at USD 90.65 billion in 2025, is projected to reach USD 186.71 billion by 2034, growing at a CAGR of 8.25%, driven by rising demand for rapid diagnostics and healthcare innovation.
Point-of-care Biosensors Market Size Analysis
Point-of-care Biosensors Market Size By Product 2025 to 2034 (USD Billion)
| Product | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Glucose Monitoring | 10.07 | 10.62 | 11.45 | 12.73 | 14.14 | 15.14 | 15.84 | 17.02 | 18.25 | 19.88 |
| HIV | 18.47 | 20.48 | 22.70 | 24.69 | 26.05 | 28.28 | 31.21 | 34.51 | 36.67 | 39.92 |
| Hepatitis C | 26.86 | 28.33 | 29.74 | 31.26 | 32.67 | 35.29 | 36.83 | 38.52 | 40.30 | 45.31 |
| Pregnancy | 35.25 | 38.70 | 42.33 | 46.31 | 51.61 | 56.03 | 61.98 | 67.84 | 75.70 | 79.91 |
Point-of-care Biosensors Market Size By Platforms 2025 to 2034 (USD Billion)
| Platforms | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Microfluidics | 13.43 | 14.37 | 15.37 | 16.12 | 17.45 | 18.98 | 20.08 | 20.92 | 22.30 | 23.26 |
| Dipsticks | 30.22 | 32.22 | 36.21 | 38.05 | 41.92 | 46.21 | 48.89 | 53.33 | 56.71 | 61.25 |
| Immunoassays | 47.00 | 51.54 | 54.64 | 60.82 | 65.10 | 69.55 | 76.89 | 83.64 | 91.91 | 100.51 |
Point-of-care Biosensors Market Size By Purchase 2025 to 2034 (USD Billion)
| Purchase | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| OTC | 20.14 | 21.25 | 22.46 | 24.96 | 26.52 | 28.01 | 29.32 | 31.00 | 33.46 | 36.87 |
| Prescription | 70.51 | 76.88 | 83.76 | 90.03 | 97.95 | 106.73 | 116.54 | 126.89 | 137.46 | 148.15 |
Point-of-care Biosensors Market Size By Sample 2025 to 2034 (USD Billion)
| Sample | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Blood | 20.14 | 22.64 | 25.17 | 27.67 | 30.09 | 32.44 | 35.02 | 37.50 | 42.95 | 45.66 |
| Urine | 70.51 | 75.49 | 81.05 | 87.32 | 94.38 | 102.30 | 110.84 | 120.39 | 127.97 | 139.36 |
Point-of-care Biosensors Market Size By End User 2025 to 2034 (USD Billion)
| End User | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacy | 13.43 | 14.07 | 15.52 | 16.18 | 17.74 | 19.29 | 20.81 | 22.44 | 23.65 | 26.29 |
| Hospital | 30.22 | 32.88 | 35.42 | 39.50 | 40.61 | 44.78 | 48.85 | 51.35 | 56.64 | 63.76 |
| Homecare | 47.00 | 51.18 | 55.28 | 59.31 | 66.12 | 70.67 | 76.20 | 84.10 | 90.63 | 94.97 |
Point-of-care Biosensors Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 8.06 | 8.94 | 10.09 | 10.65 | 11.56 | 12.41 | 13.40 | 14.70 | 16.05 | 16.72 |
| Europe | 13.09 | 14.36 | 15.49 | 16.76 | 17.97 | 19.67 | 20.57 | 22.44 | 23.98 | 25.71 |
| Asia Pacific | 18.13 | 19.73 | 22.30 | 23.87 | 25.53 | 28.16 | 30.62 | 31.98 | 35.05 | 39.36 |
| Latin America | 23.17 | 24.87 | 26.20 | 29.39 | 32.05 | 34.92 | 37.33 | 42.05 | 46.61 | 48.90 |
| Middle East and Africa | 28.20 | 30.23 | 32.14 | 34.32 | 37.36 | 39.58 | 43.94 | 46.72 | 49.23 | 54.33 |
Point-of-care Biosensors Market Size to Attain USD 186.71 Billion by 2034
The global point-of-care biosensors market size accounted for USD 90.65 billion in 2025 and is predicted to touch around USD 186.71 billion by 2034 a CAGR of 8.25%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
